AMZN vs. JNJ: Amazon.com vs. Johnson & Johnson Stock Comparison
How do Amazon.com (AMZN) and Johnson & Johnson (JNJ) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Amazon.com (AMZN) is classified in the Consumer Discretionary sector (Consumer Discretionary Distribution & Retail), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AMZN | JNJ |
|---|---|---|
| Name | Amazon.com Inc. | Johnson & Johnson |
| Country/Region | United States | United States |
| GICS Sector | Consumer Discretionary | Health Care |
| GICS Industry Group | Consumer Discretionary Distribution & Retail | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Broadline Retail | Pharmaceuticals |
| GICS Sub-Industry | Broadline Retail | Pharmaceuticals |
| Market Capitalization | 2,803.85 billion USD | 664.95 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | May 15, 1997 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| Total Return (1Y) | 9.80% | 53.82% |
| Total Return (3Y, Annualized) | 24.05% | 27.51% |
| Total Return (5Y, Annualized) | 8.46% | 14.71% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
Amazon.com (AMZN) has an aggressive beta of 1.45, indicating higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.
| Metric | AMZN | JNJ |
|---|---|---|
| Volatility (1Y, Annualized) | 34.10% | 21.23% |
| Beta (5Y) | 1.45 | 0.21 |
| Max Drawdown (5Y) | -55.73% | -18.41% |
| Avg. Volume (3M) | 38.50M | 6.93M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| Sharpe Ratio (1Y) | 0.16 | 2.33 |
| Sortino Ratio (1Y) | 0.26 | 3.66 |
Profitability
ROE (TTM)
Johnson & Johnson (JNJ) at 20.02% sits in the top ROE quartile, while Amazon.com (AMZN) at 27.42% is closer to the peer norm — stronger capital efficiency for JNJ.
AMZN
Consumer Discretionary Distribution & Retail industry group
27.42%
- Max
- 62.17%
- Q3
- 29.44%
- AMZN
- 27.42%
- Median
- 15.69%
- Q1
- 6.73%
- Min
- -12.16%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
20.02%
- Max
- 109.18%
- JNJ
- 20.02%
- Q3
- 6.23%
- Median
- -26.66%
- Q1
- -64.05%
- Min
- -167.77%
Net Margin (TTM)
For every dollar of sales, both Amazon.com (AMZN) at 16.90% and Johnson & Johnson (JNJ) at 16.20% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
AMZN
Consumer Discretionary Distribution & Retail industry group
16.90%
- Max
- 16.94%
- AMZN
- 16.90%
- Q3
- 8.69%
- Median
- 3.55%
- Q1
- 1.14%
- Min
- -9.41%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
16.20%
- Max
- 18.05%
- JNJ
- 16.20%
- Q3
- 4.78%
- Median
- 0.00%
- Q1
- -4.14%
- Min
- -17.05%
Operating Margin (TTM)
Both Amazon.com (AMZN) at 13.90% and Johnson & Johnson (JNJ) at 25.74% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AMZN
Consumer Discretionary Distribution & Retail industry group
13.90%
- Max
- 21.45%
- AMZN
- 13.90%
- Q3
- 10.89%
- Median
- 5.57%
- Q1
- 2.28%
- Min
- -7.12%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
25.74%
- Max
- 83.12%
- JNJ
- 25.74%
- Q3
- 14.77%
- Median
- 0.00%
- Q1
- -78.82%
- Min
- -207.40%
Profitability Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| ROE (TTM) | 27.42% | 20.02% |
| ROA (TTM) | 6.62% | 8.46% |
| Net Margin (TTM) | 16.90% | 16.20% |
| Operating Margin (TTM) | 13.90% | 25.74% |
| Gross Margin (TTM) | 51.37% | 67.78% |
Growth
Revenue Growth
Amazon.com (AMZN) at 12.38% sits in the top revenue growth quartile, while Johnson & Johnson (JNJ) at 6.05% is closer to the peer norm — faster top-line expansion for AMZN.
EPS Growth
Both Amazon.com (AMZN) at 29.66% and Johnson & Johnson (JNJ) at 90.50% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.
Growth Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| Revenue Growth (YoY) | 12.38% | 6.05% |
| Revenue Growth (3Y CAGR) | 11.73% | 5.60% |
| EPS Growth (YoY) | 29.66% | 90.50% |
| EPS Growth (3Y CAGR) | -- | 17.90% |
Financial Strength
Current Ratio (MRQ)
Both Amazon.com (AMZN) at 0.99 and Johnson & Johnson (JNJ) at 1.02 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.99
- Max
- 2.62
- Q3
- 1.75
- Median
- 1.35
- Q1
- 1.00
- AMZN
- 0.99
- Min
- 0.48
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.02
- Max
- 25.13
- Q3
- 12.13
- Median
- 5.52
- Q1
- 2.47
- JNJ
- 1.02
- Min
- 0.10
Debt / Equity (MRQ)
Amazon.com (AMZN) at 0.50 keeps leverage in the lower industry quartile, while Johnson & Johnson (JNJ) at 0.55 runs a more typical debt-to-equity mix.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.50
- Max
- 3.93
- Q3
- 2.14
- Median
- 1.25
- Q1
- 0.73
- AMZN
- 0.50
- Min
- 0.01
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.55
- Max
- 1.42
- Q3
- 0.65
- JNJ
- 0.55
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 0.99 | 1.02 |
| Debt / Equity (MRQ) | 0.50 | 0.55 |
| Net Debt / EBITDA | 1.04 | 0.79 |
Dividends
Dividend Yield (TTM)
Amazon.com (AMZN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a yield of 1.94%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 5.84%
- Q3
- 2.50%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.94%
- JNJ
- 1.94%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Amazon.com (AMZN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Johnson & Johnson (JNJ) reports a payout of 80.12%, ranking against industry peers normally.
AMZN
Consumer Discretionary Distribution & Retail industry group
0.00%
- Max
- 72.73%
- Q3
- 32.44%
- AMZN
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
80.12%
- JNJ
- 80.12%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.94% |
| Dividend Payout Ratio (TTM) | 0.00% | 80.12% |
Valuation
P/E Ratio (TTM)
Both Amazon.com (AMZN) at 20.96 and Johnson & Johnson (JNJ) at 41.92 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AMZN
Consumer Discretionary Distribution & Retail industry group
20.96
- Max
- 40.50
- Q3
- 24.26
- AMZN
- 20.96
- Median
- 19.23
- Q1
- 12.64
- Min
- 4.67
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
41.92
- Max
- 85.34
- Q3
- 43.46
- JNJ
- 41.92
- Median
- 26.69
- Q1
- 13.30
- Min
- 0.07
P/S Ratio (TTM)
Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while Amazon.com (AMZN) at 3.52 sits in the pricier quartile — AMZN costs more per dollar of sales.
AMZN
Consumer Discretionary Distribution & Retail industry group
3.52
- Max
- 4.32
- AMZN
- 3.52
- Q3
- 1.99
- Median
- 0.70
- Q1
- 0.26
- Min
- 0.03
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.69
- Max
- 58.18
- Q3
- 25.77
- Median
- 7.30
- JNJ
- 6.69
- Q1
- 3.01
- Min
- 0.01
P/B Ratio (MRQ)
Amazon.com (AMZN) at 4.57 is valued about in line with its industry on P/B ratio, while Johnson & Johnson (JNJ) at 8.16 carries an above-peer premium to book — JNJ is pricier on assets.
AMZN
Consumer Discretionary Distribution & Retail industry group
4.57
- Max
- 10.96
- Q3
- 5.26
- AMZN
- 4.57
- Median
- 2.16
- Q1
- 1.08
- Min
- -4.45
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
8.16
- Max
- 13.53
- JNJ
- 8.16
- Q3
- 6.54
- Median
- 3.25
- Q1
- 1.69
- Min
- -5.59
Valuation Metrics
| Metric | AMZN | JNJ |
|---|---|---|
| P/E Ratio (TTM) | 20.96 | 41.92 |
| P/S Ratio (TTM) | 3.52 | 6.69 |
| P/B Ratio (MRQ) | 4.57 | 8.16 |
| Free Cash Flow Yield (TTM) | -1.24% | 2.78% |